Viz.ai Named One of the World’s Most Innovative Companies by Fast Company Magazine
Viz.ai joins the ranks of distinguished businesses that are paving the way for innovations of tomorrow on Fast Company’s World’s...
Mar 19, 2024
All Resources
Explore our latest resources
Viz.ai Broadens Healthcare System Integrations to Inform Critical Decisions at the Point of...
Integration capabilities deliver real-time, disease-specific insights to healthcare providers to improve patient care and outcomes SAN FRANCISCO – March 12,...
Mar 12, 2024
Mar 11, 2024
New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism
Company’s artificial intelligence technology shows 74% reduction in in-hospital mortality rates for pulmonary embolism SAN FRANCISCO – March 7, 2024...
Mar 07, 2024
Unlocking New Frontiers in Stroke Management: Highlights from the 2024 International Stroke Conference...
Every year, the International Stroke Conference (ISC) brings together medical professionals, researchers, and experts from around the globe to discuss...
Mar 04, 2024
February 29, 2024
Viz.ai Announces Successful Completion of SOC 2 Type II + HIPAA Audits for...
Validates Viz.ai as a trusted and secure platform for health systems for the fourth consecutive year SAN FRANCISCO – February...
Feb 26, 2024
Navigating the Future of Healthcare: Viz.ai’s Insights from J.P. Morgan Healthcare Conference 2024
The 2024 J.P. Morgan Healthcare Conference provided a robust platform for leaders, innovators, and disruptors in the healthcare industry to...
Feb 09, 2024
Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of...
New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisions SAN FRANCISCO...
Feb 08, 2024